VT

Vadlamudi Tharanath

Active Director Designated Partner DIN 09476395
DIN 09476395 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vadlamudi Tharanath

Data last updated:

Vadlamudi Tharanath is a Designated Partner at Avigna Laboratories Tirupati Llp (since 2022). The company operates in Healthcare.

DIN 09476395
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jan 20222022Active

Board colleagues of Vadlamudi Tharanath

Directorship timeline

Open interactive timeline →
Avigna Laboratories Tirupati Llp
Premium access

Shareholding and investment profile for Vadlamudi Tharanath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vadlamudi Tharanath

Vadlamudi Tharanath currently holds 1 directorship: Avigna Laboratories Tirupati Llp (Designated Partner, since 21 Jan 2022).

Vadlamudi Tharanath was first appointed on 21 Jan 2022 as Designated Partner at Avigna Laboratories Tirupati Llp.

The current boards of Vadlamudi Tharanath's companies include Arief Basha Shaik (Avigna Laboratories Tirupati Llp), Kishore Animireddy (Avigna Laboratories Tirupati Llp), Siva Prasada Rao Jampani (Avigna Laboratories Tirupati Llp), Subramanyam Singiri (Avigna Laboratories Tirupati Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available